Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026)

Ufp Technologies (UFPT) reported Total Non-Current Liabilities of $234.0 million for Q1 2026, down 15.47% on a YoY basis from $276.9 million in Q1 2025, and up 2.8% quarter-over-quarter from $227.7 million in Q4 2025.

Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Ufp Technologies has reported Total Non-Current Liabilities for 16 years, with the latest figure at $234.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 15.47% year-over-year to $234.0 million; the trailing twelve-month figure through Mar 2026 stood at $234.0 million (down 15.47% YoY), and the FY2025 full-year result was $227.7 million, down 17.24% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $234.0 million, up from $227.7 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $304.6 million in Q3 2024, with the low at $104.3 million in Q1 2024.
  • Historically, Total Non-Current Liabilities has averaged $185.7 million across 5 years, with a median of $144.7 million in 2022.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 529.29% — and 2024, when it decreased 27.21%.
  • Ufp Technologies' Total Non-Current Liabilities stood at $140.2 million in 2022, then retreated by 21.55% to $109.9 million in 2023, then jumped by 150.2% to $275.1 million in 2024, then retreated by 17.24% to $227.7 million in 2025, then rose by 2.8% to $234.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $234.0 million (Q1 2026), $227.7 million (Q4 2025), and $244.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 20.94 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 2.44 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 3.53 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 24.21 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 3.47 Bn
10 Ufp Technologies 1.85 Bn 1.83 Bn 44.36 Mn 234.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 234.05 Mn
Dec 31, 2025 227.68 Mn
Sep 30, 2025 244.63 Mn
Jun 30, 2025 248.92 Mn
Mar 31, 2025 276.89 Mn
Dec 31, 2024 275.09 Mn
Sep 30, 2024 304.61 Mn
Jun 30, 2024 108.25 Mn
Mar 31, 2024 104.33 Mn
Dec 31, 2023 109.95 Mn
Sep 30, 2023 126.93 Mn
Jun 30, 2023 137.21 Mn
Mar 31, 2023 143.33 Mn
Dec 31, 2022 140.15 Mn
Sep 30, 2022 142.61 Mn
Jun 30, 2022 187.79 Mn
Mar 31, 2022 144.71 Mn
Dec 31, 2021 124.50 Mn
Sep 30, 2021 28.86 Mn
Jun 30, 2021 29.84 Mn